[A gaschromatographic method for the simultaneous determination of ethosuximide and valproate in serum (author's transl)]. 1980

W R Külpmann

A gaschromatographic procedure for the simultaneous determination of ethosuximide and valproate is presented. After addition of the two internal standards the serum sample is acidified and extracted by chloroform. 2 microliters of the organic phase is directly injected into the gaschromatograph without previous evaporation. The gaschromatographic analysis is carried out on SP 1000 under isothermal conditions without derivatisation. The coefficients of variation for the precision from day to day were 2.6% (ethosuximide) and 5.2% (valproate). In external quality control the results for both substances always differed less than one standard deviation from the mean. The detection limits (11.6 mumol/l for ethosuximide and 2.3 mumol/l for valproate) were far below the usual therapeutic range. The specificity of the method was proven by comparison of the relative retention times of about 100 drugs, the investigated antiepileptic drugs and their internal standards.

UI MeSH Term Description Entries
D008832 Microchemistry The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005013 Ethosuximide An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. Ethosuccimid,Emeside,Ethylmethylsuccimide,Ethymal,Etosuximida Faes,Petnidan,Pyknolepsinum,Suksilep,Suxilep,Zarontin,Faes, Etosuximida
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

W R Külpmann
July 1976, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
W R Külpmann
September 1971, Zeitschrift fur klinische Chemie und klinische Biochemie,
W R Külpmann
January 1975, S & TA & NU. Rivista di scienza e tecnologia degli alimenti e di nutrizione umana,
W R Külpmann
March 1975, Zeitschrift fur klinische Chemie und klinische Biochemie,
Copied contents to your clipboard!